vs
AVINO SILVER & GOLD MINES LTD（ASM）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
AVINO SILVER & GOLD MINES LTD的季度营收约是礼来的1.7倍（$21.0M vs $12.5M），AVINO SILVER & GOLD MINES LTD净利率更高（36.6% vs -1398.3%，领先1434.9%），礼来同比增速更快（434.0% vs 44.0%），过去两年礼来的营收复合增速更高（138.5% vs 51.1%）
阿维诺金银矿业有限公司是一家加拿大矿业企业，主要从事银、金、铜等贵金属及基本金属的勘探、开发与生产，核心运营资产为位于墨西哥杜兰戈州的旗舰阿维诺矿区，产品供应全球大宗商品市场。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
ASM vs RNA — 直观对比
营收规模更大
ASM
是对方的1.7倍
$12.5M
营收增速更快
RNA
高出390.1%
44.0%
净利率更高
ASM
高出1434.9%
-1398.3%
两年增速更快
RNA
近两年复合增速
51.1%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.0M | $12.5M |
| 净利润 | $7.7M | $-174.4M |
| 毛利率 | 47.1% | — |
| 营业利润率 | — | -1513.5% |
| 净利率 | 36.6% | -1398.3% |
| 营收同比 | 44.0% | 434.0% |
| 净利润同比 | 558.9% | -117.0% |
| 每股收益（稀释后） | $0.05 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMRNA
| Q3 25 | $21.0M | $12.5M | ||
| Q2 25 | $21.8M | $3.8M | ||
| Q1 25 | $18.8M | $1.6M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $14.6M | $2.3M | ||
| Q2 24 | $14.8M | $2.0M | ||
| Q1 24 | $12.4M | $3.5M | ||
| Q4 23 | — | $2.2M |
净利润ASMRNA
| Q3 25 | $7.7M | $-174.4M | ||
| Q2 25 | $2.9M | $-157.3M | ||
| Q1 25 | $5.6M | $-115.8M | ||
| Q4 24 | — | $-102.3M | ||
| Q3 24 | $1.2M | $-80.4M | ||
| Q2 24 | $1.2M | $-70.8M | ||
| Q1 24 | $599.0K | $-68.9M | ||
| Q4 23 | — | $-60.4M |
毛利率ASMRNA
| Q3 25 | 47.1% | — | ||
| Q2 25 | 46.9% | — | ||
| Q1 25 | 56.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 39.1% | — | ||
| Q2 24 | 31.8% | — | ||
| Q1 24 | 18.9% | — | ||
| Q4 23 | — | — |
营业利润率ASMRNA
| Q3 25 | — | -1513.5% | ||
| Q2 25 | — | -4448.7% | ||
| Q1 25 | — | -8360.9% | ||
| Q4 24 | — | -4069.6% | ||
| Q3 24 | — | -4200.9% | ||
| Q2 24 | — | -4040.4% | ||
| Q1 24 | — | -2178.6% | ||
| Q4 23 | — | -3043.5% |
净利率ASMRNA
| Q3 25 | 36.6% | -1398.3% | ||
| Q2 25 | 13.1% | -4089.3% | ||
| Q1 25 | 29.8% | -7360.0% | ||
| Q4 24 | — | -3439.5% | ||
| Q3 24 | 8.0% | -3441.7% | ||
| Q2 24 | 8.4% | -3461.8% | ||
| Q1 24 | 4.8% | -1943.4% | ||
| Q4 23 | — | -2756.2% |
每股收益（稀释后）ASMRNA
| Q3 25 | $0.05 | $-1.27 | ||
| Q2 25 | $0.02 | $-1.21 | ||
| Q1 25 | $0.04 | $-0.90 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $0.01 | $-0.65 | ||
| Q2 24 | $0.01 | $-0.65 | ||
| Q1 24 | $0.00 | $-0.79 | ||
| Q4 23 | — | $-0.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.3M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.1M | $1.9B |
| 总资产 | $221.9M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMRNA
| Q3 25 | $57.3M | $350.2M | ||
| Q2 25 | $37.3M | $243.9M | ||
| Q1 25 | $26.6M | $254.2M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | $7.8M | $370.2M | ||
| Q2 24 | $5.3M | $575.8M | ||
| Q1 24 | $3.5M | $471.4M | ||
| Q4 23 | — | $185.1M |
股东权益ASMRNA
| Q3 25 | $182.1M | $1.9B | ||
| Q2 25 | $144.8M | $1.2B | ||
| Q1 25 | $132.3M | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $114.5M | $1.5B | ||
| Q2 24 | $112.2M | $1.2B | ||
| Q1 24 | $107.8M | $830.9M | ||
| Q4 23 | — | $500.8M |
总资产ASMRNA
| Q3 25 | $221.9M | $2.1B | ||
| Q2 25 | $174.7M | $1.4B | ||
| Q1 25 | $157.7M | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $135.4M | $1.6B | ||
| Q2 24 | $133.7M | $1.3B | ||
| Q1 24 | $128.6M | $951.5M | ||
| Q4 23 | — | $628.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.3M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-156.9M |
| 自由现金流率自由现金流/营收 | — | -1257.6% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | 1.08× | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势，按日历期对齐
经营现金流ASMRNA
| Q3 25 | $8.3M | $-156.2M | ||
| Q2 25 | $8.3M | $-199.7M | ||
| Q1 25 | $758.0K | $-124.8M | ||
| Q4 24 | — | $-99.9M | ||
| Q3 24 | $4.1M | $-65.6M | ||
| Q2 24 | $1.1M | $-65.0M | ||
| Q1 24 | $2.3M | $-70.4M | ||
| Q4 23 | — | $16.5M |
自由现金流ASMRNA
| Q3 25 | — | $-156.9M | ||
| Q2 25 | — | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M | ||
| Q4 23 | — | $15.6M |
自由现金流率ASMRNA
| Q3 25 | — | -1257.6% | ||
| Q2 25 | — | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% | ||
| Q4 23 | — | 713.1% |
资本支出强度ASMRNA
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 86.9% | ||
| Q1 25 | — | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% | ||
| Q4 23 | — | 39.4% |
现金转化率ASMRNA
| Q3 25 | 1.08× | — | ||
| Q2 25 | 2.92× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.55× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 3.92× | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
